tag:blogger.com,1999:blog-36634196.post2708113151309652132..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: If FDA Pulls a Drug, Which One Will It Be?Chris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger7125tag:blogger.com,1999:blog-36634196.post-38427988384477261522009-03-24T15:48:00.000-05:002009-03-24T15:48:00.000-05:00Ramsey is a kid who knows little. To think FDA wou...Ramsey is a kid who knows little. To think FDA would yank a drug to make the point as you say "that it is no longer business as usual at FDA" is ridiculous. With orange juice, makers called Kessler's bluff. There's no comparison... do you think companies would make safer products if they could? They don't intentionally make risky drugs.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-28600667654405402092009-03-21T18:47:00.000-05:002009-03-21T18:47:00.000-05:00I agree with Avelox. Or if they pull all the warn...I agree with Avelox. Or if they pull all the warnings from different counties maybe all the quinolones. The MDL lawsuit over tendons is just the begining.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-19223768086657675882009-03-20T12:08:00.000-05:002009-03-20T12:08:00.000-05:00In fact, the FDA's deadly overcaution costs far mo...In fact, the FDA's deadly overcaution costs far more suffering and lives than the negative effects of drugs that are licensed. Nor is the FDA competent to supervise or execute post-marketing approval. New study out today: http://tinyurl.com/dbx7rx.John R. Grahamhttps://www.blogger.com/profile/09420909459359064358noreply@blogger.comtag:blogger.com,1999:blog-36634196.post-51540506792613407702009-03-20T08:16:00.000-05:002009-03-20T08:16:00.000-05:00Perhaps not until 2010, and not significant enough...Perhaps not until 2010, and not significant enough of a market, but my bet is on Midodrine. <BR/>http://www.fda.gov/ohrms/dockets/dockets/07n0311/07n0311.htm<BR/>The FDA has actually threatened to withdraw the product from the market unless the Phase IV program is completed, but the drug is completely generic at this point, and some new company is applying for a new drug in this indication later in 2009.<BR/>I think pulling a smaller drug off the market where companies failed to meet their promises may be more likely than the FDA admitting they were wrong when they approved a major market drug.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-67795918093004043232009-03-19T13:17:00.000-05:002009-03-19T13:17:00.000-05:00what about Avelox (moxifloxacin)? Got recent craz...what about Avelox (moxifloxacin)? Got recent crazy warnings in Europe, but none here.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-9729078392226334392009-03-19T12:15:00.000-05:002009-03-19T12:15:00.000-05:00What about Oxycontin?What about Oxycontin?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-36634196.post-2240162290946487562009-03-19T09:56:00.000-05:002009-03-19T09:56:00.000-05:00Welcome to the new millenium: the biggest rap aga...Welcome to the new millenium: the biggest rap against Accutane is IBD, not suicide. There have been three verdicts for IBD and none for suicide. Get with the program!Anonymousnoreply@blogger.com